• 1. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 2. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 3. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
• 4. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 5. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212

Research Brief on N-(2,4-Dimethylphenyl)sulfonylglycine (CAS: 670255-96-6): Recent Advances and Applications

N-(2,4-Dimethylphenyl)sulfonylglycine (CAS: 670255-96-6) is a sulfonamide derivative that has garnered significant attention in the field of chemical biology and medicinal chemistry due to its potential therapeutic applications. Recent studies have explored its role as a key intermediate in the synthesis of bioactive compounds, particularly in the development of enzyme inhibitors and anti-inflammatory agents. This research brief consolidates the latest findings on this compound, highlighting its chemical properties, biological activities, and emerging applications in drug discovery.

One of the most notable advancements in the study of N-(2,4-Dimethylphenyl)sulfonylglycine is its application in the design of matrix metalloproteinase (MMP) inhibitors. MMPs are a family of zinc-dependent endopeptidases implicated in various pathological conditions, including cancer metastasis and inflammatory diseases. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that derivatives of N-(2,4-Dimethylphenyl)sulfonylglycine exhibit potent inhibitory activity against MMP-2 and MMP-9, with IC50 values in the nanomolar range. The study utilized molecular docking and kinetic assays to elucidate the binding interactions, revealing a strong affinity for the zinc-binding domain of these enzymes.

In addition to its role in MMP inhibition, N-(2,4-Dimethylphenyl)sulfonylglycine has been investigated for its anti-inflammatory properties. A recent preclinical study published in Bioorganic & Medicinal Chemistry Letters reported that this compound significantly reduces the production of pro-inflammatory cytokines, such as TNF-α and IL-6, in macrophage cell lines. The study attributed this effect to the compound's ability to modulate the NF-κB signaling pathway, suggesting its potential as a lead compound for developing novel anti-inflammatory therapeutics.

From a synthetic chemistry perspective, N-(2,4-Dimethylphenyl)sulfonylglycine serves as a versatile building block for the preparation of sulfonamide-based drugs. A 2022 study in Organic & Biomolecular Chemistry detailed an efficient, one-pot synthesis method for this compound, employing green chemistry principles to minimize environmental impact. The optimized protocol achieved a high yield (85%) and purity (>98%), making it suitable for large-scale pharmaceutical production.

Despite these promising developments, challenges remain in the clinical translation of N-(2,4-Dimethylphenyl)sulfonylglycine-based therapeutics. Pharmacokinetic studies indicate that the compound exhibits moderate bioavailability and requires further structural optimization to enhance its metabolic stability. Ongoing research is focused on designing prodrugs and nanoformulations to address these limitations, as highlighted in a 2023 review article in Advanced Drug Delivery Reviews.

In conclusion, N-(2,4-Dimethylphenyl)sulfonylglycine (CAS: 670255-96-6) represents a promising scaffold for drug discovery, with demonstrated applications in enzyme inhibition and anti-inflammatory therapy. Continued research into its mechanism of action and drug delivery strategies will be critical for advancing its therapeutic potential. This brief underscores the importance of interdisciplinary collaboration in translating chemical discoveries into clinically viable treatments.

• 379250-94-9(2-(2,3,5,6-tetramethylbenzenesulfonamido)acetic acid)
• 670255-99-9(N-(4-Ethylphenyl)sulfonylglycine)
• 96919-70-9(Glycine, N-[(4-ethylphenyl)sulfonyl]-, monoammonium salt (9CI))
• 1080-44-0(N-p-Tosylglycine)
• 496026-17-6(2-2-(Trifluoromethyl)benzenesulfonamidoacetic Acid)
• 19829-14-2(Benzenesulfonamide, N-(2-hydroxyethyl)-2-methyl-)
• 1009671-00-4(2-(2,3,5,6-tetramethylbenzenesulfonamido)propanoic acid)
• 13240-18-1(2-(2,5-dimethylbenzenesulfonamido)acetic acid)
• 139937-38-5(Glycine, N-[(4-bromo-2-methylphenyl)sulfonyl]-)
• 670260-30-7(N-(4-Fluoro-2-methylphenyl)sulfonylglycine)